My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Gayatri Projects advances as board to consider stock-split proposal
Dec 19,2016

The announcement was made on Saturday, 17 December 2016.

Meanwhile, the S&P BSE Sensex was down 74.11 points, or 0.28%, to 26,415.45

On BSE, so far 1,474 shares were traded in the counter, compared with average daily volume of 6,364 shares in the past one quarter. The stock hit a high of Rs 618 and a low of Rs 610 so far during the day. The stock hit a 52-week low of Rs 482 on 17 February 2016. The stock hit a record high of Rs 790 on 23 September 2016.

The small-cap company has an equity capital of Rs 35.45 crore. Face value per share is Rs 10.

Gayatri Projects net profit jumped 53.5% to Rs 11.62 crore on 10.19% growth in total income to Rs 351.05 crore in Q2 September 2016 over Q2 September 2015.

Gayatri Projects is a Hyderabad-based infrastructure and construction company with a presence across the segment, and a special focus on road and irrigation projects.

Powered by Capital Market - Live News

PSU OMCs rise after hike in fuel prices
Dec 19,2016

BPCL (up 2.66%), HPCL (up 1.73%) and Indian Oil Coporation (IOCL) (up 1.59%), edged higher.

Meanwhile, the S&P BSE Sensex was down 77.93 points, or 0.29% at 26,411.63.

IOCL on Friday, 16 December 2016, announced an increase in the price of petrol and diesel with effect from the midnight of 16/17 December 2016. Petrol price was hiked by Rs 2.21 per litre and diesel price was raised by Rs 1.79 a litre at Delhi (excluding state levies).

The current level of international product prices of petrol & diesel and rupee-dollar exchange rate warrant increase in selling price of petrol and diesel, the impact of which is being passed on to the consumers with this price revision, IOCL said in a statement. The movement of prices in the international oil market and rupee-dollar exchange rate shall continue to be monitored closely and developing trends of the market will be reflected in future price changes, it added.

The government decontrolled petrol & diesel prices. Public sector oil marketing companies (PSU OMCs) undertake fuel price review twice during the month based on the trend in international oil market. The first price review takes place during the middle of the month and the second on the last day of the month.

Powered by Capital Market - Live News

Anuh Pharma surges after manufacturing site gets EUGMP certificate
Dec 16,2016

The announcements were made during market hours today, 16 December 2016.

Meanwhile, the BSE Sensex was up 9.07 points, or 0.03%, to 26,528.14.

High volumes were witnessed on the counter. On the BSE, 1.35 lakh shares were traded in the counter so far, compared with an average volume of 14,594 shares in the past one quarter. The stock had hit a high of Rs 245 and a low of Rs 208.35 so far during the day. The stock had hit a 52-week high of Rs 344 on 21 December 2015. The stock had hit a 52-week low of Rs 159 on 21 April 2016.

Anuh Pharma announced that French National Agency for Medicines and Health Products Safety (ANSM) considers manufacturing site of Anuh Pharma at E-17/3 and E-17/4, MIDC Tarapur, Taluka Palghar, District Thane 401506, Boisar, Maharashtra, India site in compliance with principles of good manufacturing practices (GMP) for active substances referred to in Article 47 of directive 2001/83/EC and has granted European Union good manufacturing practices (EUGMP) certificate for Erythromycin Ethyl Succinate and Pyrazinamide products.

ANSM had carried out the inspection of the manufacturing site on 16 September 2016.

Separately, Anuh Pharma announced that World Health Organisation (WHO), Geneva, considers the manufacturing site of the company at E-17/3 and E-17/4, M.I.D.C. Tarapur, Taluka Palghar, District Thane 401506, Boisar, Maharashtra, India in compliance to WHO GMPs for Pyrazinamide APIMF158and Sulfadoxine APIMF234, active pharmaceutical ingredients.

The inspection of the manufacturing site by the WHO was carried out on 16 September 2016.

Anuh Pharmas net profit dropped 34.5% to Rs 4.87 crore on 44.2% drop in net sales to Rs 50.07 crore in Q2 September 2016 over Q2 September 2015.

Anuh Pharma manufactures active pharmaceutical ingredients (APIs). The company is one of the largest producers of macrolides in the country.

Powered by Capital Market - Live News

A2Z Infra Engg advances after contract win by its subsidiary
Dec 16,2016

The announcement was made during market hours today, 16 December 2016.

Meanwhile, the S&P BSE Sensex was down 10.90 points or 0.04% at 26,508.17.

On the BSE, 3.12 lakh shares were traded on the counter so far as against the average daily volumes of 2.87 lakh shares in the past one quarter. The stock had hit a high of Rs 44 and a low of Rs 41.75 so far during the day. The stock had hit a 52-week high of Rs 51.65 on 1 November 2016 and a 52-week low of Rs 16.50 on 12 February 2016.

The stock had outperformed the market over the past one month till 15 December 2016, gaining 15.66% compared with the 0.82% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 9.35% as against Sensexs 6.67% decline.

The small-cap company has equity capital of Rs 130.10 crore. Face value per share is Rs 10.

A2Z Infra Engineering announced that Delhi Metro Rail Corporation (DMRC), a joint venture of Government of India and Government of Delhi has awarded three facility management services contacts to A2Z Infraservices, a material subsidiary of the company.

The aggregate value of the contracts is Rs 39.31 crore, excluding service tax with additional increase in actual wages.

A2Z Infra Engineering reported net loss of Rs 16.65 crore in Q2 September 2016, higher than net loss of Rs 8.40 crore in Q2 September 2015. The companys net sales declined 42.7% to Rs 149.38 crore in Q2 September 2016 over Q2 September 2015.

A2Z Infra Engineering (formerly known as A2Z Maintenance & Engineering Services) is a fast growing, fully integrated electrical business group (EBG) in India catering to the needs of domestic and international power sector clients in building distribution and transmission infrastructure.

Powered by Capital Market - Live News

Volumes jump at Clariant Chemicals (India) counter
Dec 16,2016

Clariant Chemicals (India) clocked volume of 31.92 lakh shares by 13:53 IST on BSE, a 884.41-times surge over two-week average daily volume of 4,000 shares. The stock rose 5.16% to Rs 738.20.

KEI Industries notched up volume of 36.69 lakh shares, a 186.52-fold surge over two-week average daily volume of 20,000 shares. The stock rose 5.81% to Rs 126.55.

Shree Cement saw volume of 61,000 shares, a 102.75-fold surge over two-week average daily volume of 1,000 shares. The stock fell 1.12% to Rs 14,529.95.

Crompton Greaves Consumer Electricals clocked volume of 20.69 lakh shares, a 84.85-fold surge over two-week average daily volume of 24,000 shares. The stock rose 0.95% to Rs 143.

PTC India saw volume of 61.32 lakh shares, a 68.77-fold rise over two-week average daily volume of 89,000 shares. The stock rose 2.27% to Rs 76.60.

Powered by Capital Market - Live News

Havells India leads losers in A group
Dec 16,2016

Havells India slipped 4.44% at Rs 321.50. The stock was the second biggest loser in A group. On the BSE, 74,000 shares were traded on the counter so far as against the average daily volumes of 84,000 shares in the past two weeks.

Edelweiss Financial Services fell 4.1% to Rs 84.30. The stock was the third biggest loser in A group. On the BSE, 1.83 lakh shares were traded on the counter so far as against the average daily volumes of 1.32 lakh shares in the past two weeks.

Jaiprakash Power Ventures shed 4.09% to Rs 3.75 at 13:45 IST. The stock topped the losers in the BSEs A group. On the BSE, 5.09 lakh shares were traded on the counter so far as against the average daily volumes of 1.56 lakh shares in the past two weeks.

Hindalco Industries declined 3.55% to Rs 169.90. The stock was the fourth biggest loser in A group. On the BSE, 6.99 lakh shares were traded on the counter so far as against the average daily volumes of 10.63 lakh shares in the past two weeks.

Intellect Design Arena dropped 3.42% at Rs 156.50. The stock was the fifth biggest loser in A group. On the BSE, 1.53 lakh shares were traded on the counter so far as against the average daily volumes of 3.27 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Swan Energy surges after Gujarat govt invests equity in its LNG port project
Dec 16,2016

The announcement was made during market hours today, 16 December 2016.

Meanwhile, the S&P BSE Sensex was down 24.42 points or 0.12% at 26,485.80.

High volumes were witnessed on the counter. On the BSE, 14.89 lakh shares were traded in the counter so far as against average daily volume of 4.16 lakh shares in the past one quarter. The stock had hit a high of Rs 210.25 and a low of Rs 193.90 so far during the day. The stock had hit a record high of Rs 213.40 on 14 December 2016. The stock had hit a 52-week low of Rs 57.50 on 16 May 2016.

The stock had outperformed the market over the past one month till 15 December 2016, surging 41.79% compared with the 0.82% rise in the Sensex. The scrip had also outperformed the market in past one quarter, jumping 204.39% as against Sensexs 6.67% decline.

The mid-cap company has an equity capital of Rs 22.12 crore. Face value per share is Re 1.

Swan Energy is developing Indias first liquified natural gas (LNG) port along with floating and regasification unit (FSRU) near Jafrabad in Gujarat state with a total investment of Rs 5900 crore. A subsidiary company and special purpose vehicle company namely, Swan LNG is implementing this project.

Government of Gujarat has now decided to participate by investing 26% in equity of the LNG port project through Gujarat State Petronet and Gujarat Maritime Board jointly.

Swan Energys net profit jumped 1170.6% to Rs 2.16 crore on 1.6% growth in net sales to Rs 96.09 crore in Q2 September 2016 over Q2 September 2015.

Swan Energy is an emerging green energy company with a pipeline of innovatively structured power projects.

Powered by Capital Market - Live News

HUL edges higher after subsidiary sells certain leather business
Dec 16,2016

The announcement was made during market hours today, 16 December 2016.

Meanwhile, the S&P BSE Sensex was down 31.59 points or 0.12% at 26,487.48.

On the BSE, 19,217 shares were traded in the counter so far as against average daily volume of 70,041 shares in the past one quarter. The stock had hit a high of Rs 820.50 and a low of Rs 815.75 so far during the day. The stock had hit a 52-week high of Rs 954 on 9 September 2016. The stock had hit a 52-week low of Rs 765.35 on 27 January 2016.

Hindustan Unilever (HUL) announced that Ponds Exports (PEL), a subsidiary of HUL, engaged in the business of manufacturing of leather products, has entered into an agreement with Hindustan Foods for sale of certain movable assets and inventory with respect to the leather business of PEL.

Hindustan Foods has thus made an entry in the leather shoes exports space with a global clientele.

HULs net profit rose 11.5% to Rs 1095.60 crore on 1.3% rise in net sales Rs 7697.55 crore in Q2 September 2016 over Q2 September 2015.

HUL is a leading fast moving consumer goods (FMCG) company.

Powered by Capital Market - Live News

Saksoft surges after acquiring majority stake in technology solution consulting firm
Dec 16,2016

The announcement was made after market hours yesterday, 15 December 2016.

Meanwhile, the S&P BSE Sensex was down 7.57 points or 0.03% at 26,511.50.

On the BSE, 44,998 shares were traded in the counter so far as against average daily volume of 3,344 shares in the past one quarter. The stock had hit a high of Rs 252 and a low of Rs 221.65 so far during the day.

Saksoft said that the cost of acquisition of 60% stake in DreamOrbit Softech is Rs 16.75 crore. The acquisition of the balance 40% stake in Dreamorbit will be completed in a phased manner by 2019.

DreamOrbit Softech is a technology solution consulting firm with a focus on providing IT services to the logistics industry. With this acquisition, Saksoft will further strengthen its offerings in the digital space with special emphasis on internet of things (IoT).

Incorporated in 2010, DreamOrbit has been providing specialist technology solutions for the logistics & transportation including air, land & ocean enterprises and has offices in Bengaluru (India), Delaware (USA). DreamOrbits consolidated revenues for the financial year FY 2016 was Rs 28.86 crore.

DreamOrbit has 230 employees and works with 40+ active customers. Almost all the revenues are offshore driven and cater primarily to the US market with a small portion coming in from rest of the world. DreamOrbit has been recognised in Deloitte Technology Fast 50 India for the past three years.

Saksofts consolidated net profit fell 1.06% to Rs 4.65 crore on 3.94% decline in net sales to Rs 61.43 crore in Q2 September 2016 over Q1 June 2016.

Saksoft is a provider of Information Management solutions to successful organizations around the world.

Powered by Capital Market - Live News

Alembic Pharma gains after USFDA approval for itraconazole capsules
Dec 16,2016

The announcement was made during trading hours today, 16 December 2016.

Meanwhile, the BSE Sensex was down 25.45 points, or 0.10%, to 26,493.62.

On the BSE, so far 1,314 shares were traded in the counter, compared with average daily volumes of 9,873 shares in the past one quarter. The stock had hit a high of Rs 636.75 and a low of Rs 621.55 so far during the day.

The stock hit a 52-week high of Rs 727.25 on 30 December 2015. The stock hit a 52-week low of Rs 514.35 on 5 February 2016. The stock had outperformed the market over the past 30 days till 15 December 2016, rising 1.37% compared with the 0.84% rise in the Sensex. The scrip had also outperformed the market in past one quarter, falling 5.98% as against Sensexs 7.27% decline.

The large-cap company has equity capital of Rs 37.70 crore. Face value per share is Rs 2.

Alembic Pharmaceuticals announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for itraconazole capsules, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Sporanox Capsules, 100 mg of Janssen Pharmaceuticals, Inc.

Itraconazole capsules are indicated for the treatment of blastomycosis, histoplasmosis and aspergillosis in immunocompromised and non-immunocompromised patients and onychomycosis in non-immunocompromised patients.

Itraconazole capsules had an estimated market size of $42 million for twelve months ending December 2015 according to MS. Alembic now has a total of 52 ANDA approvals (46 final approvals and 6 tentative approvals) from USFDA.

On a consolidated basis, net profit of Alembic Pharmaceuticals declined 58.47% to Rs 119.83 crore on 13.13% decline in net sales to Rs 871.56 crore in Q2 September 2016 over Q2 September 2015.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, manufactures and markets generic pharmaceutical products all over the world.

Powered by Capital Market - Live News

Confidence Petroleum hits the roof on buyback proposal
Dec 16,2016

The announcement was made after market hours yesterday, 15 December 2016.

Meanwhile, the BSE Sensex was down 34.16 points, or 0.13%, to 26,484.91.

On the BSE, so far 17,000 shares were traded in the counter, compared with average daily volumes of 3.84 lakh shares in the past one quarter.

The stock hit a 52-week high of Rs 12.16 on 4 November 2016. The stock hit a 52-week low of Rs 4.54 on 13 June 2016. The stock had underperformed the market over the past 30 days till 15 December 2016, falling 18.67% compared with the 0.84% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 7.82% as against Sensexs 7.27% decline.

The small-cap company has equity capital of Rs 25.88 crore. Face value per share is Re 1.

On a consolidated basis, net profit of Confidence Petroleum India rose 47.83% to Rs 1.02 crore on 32.99% rise in net sales to Rs 111.39 crore in Q2 September 2016 over Q2 September 2015.

Confidence Petroleum India is Indias leading LPG bottler and largest LPG cylinder manufacturing company. The allied activities include LPG marketing, auto LPG, CNG/high pressure cylinders & LPG blending.

Powered by Capital Market - Live News

Claris Lifesciences jumps after selling its global generic injectables business
Dec 16,2016

The announcement was made after market hours yesterday, 15 December 2016.

Meanwhile, the S&P BSE Sensex, was down 24.13 points or 0.09% at 26,509.35.

Huge volumes were witnessed on the counter. On the BSE, 17.12 lakh shares were traded in the counter so far, compared with an average daily volume of 2.45 lakh shares in the past one quarter. The stock had hit a high of Rs 430.10 and low of Rs 386.20 so far during the trading session.

The small cap company has equity capital of Rs 54.57 crore. Face value per share is Rs 10.

Claris Lifesciences announced that it has entered into definitive agreements with Baxter International Inc. for the sale of its global generic injectables business for a total gross consideration of $625 million.

Claris Lifesciences announced that the board of directors of the company at a meeting held yesterday, 15 December 2016 approved the sale and transfer of the injectable business of the company by way of sale of the subsidiary companies, namely, Claris Injectables Limited, Claris Pharmaservices, Elda International DMCC, Claris Lifesciences Inc., Claris Lifesciences (UK) Limited, Claris Lifesciences (Aust) Pty. Limited, and Claris Lifesciences Philippines, INC.

Claris Lifesciences said that injectible business has been growing rapidly over the last few years and has attracted significant interest. The injectable business had contributed revenue of Rs 623 crore in Claris consolidated revenue for the year ended 31 March 2016 (FY 2016), which is 78% of the companys total revenue.

The expected date of the completion of sale is within 12 months. Claris intends to repatriate a significant majority of the net cash proceeds to the shareholders.

Baxter International is a US based company which provides a broad portfolio of essential renal and hospital products.

Claris Lifesciences consolidated net profit jumped 169.9% to Rs 32.39 crore on 0.7% decline in net sales to Rs 192.13 crore in Q2 September 2016 over Q2 September 2015.

Claris Lifesciences is the holding company of Claris Injectables. Claris Injectables is a wholly-owned subsidiary of Claris Injectables dealing in specialty injectables business. Claris Lifesciences also has minority stake in Claris Otsuka Private Limited, a joint venture with Japans Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co. for Infusion business in India and emerging markets.

Powered by Capital Market - Live News

J&K Bank slips after weak Q2 results
Dec 16,2016

The result was announced after market hours yesterday, 15 December 2016.

Meanwhile, the BSE Sensex was down 16.47 points, or 0.06%, to 26,502.60.

On the BSE, so far 1.62 lakh shares were traded in the counter, compared with average daily volumes of 3.38 lakh shares in the past one quarter. The stock had hit a high of Rs 60.30 and a low of Rs 57.15 so far during the day.

The stock hit a 52-week high of Rs 91.95 on 5 October 2016. The stock hit a 52-week low of Rs 54.60 on 24 November 2016. The stock had outperformed the market over the past 30 days till 15 December 2016, rising 2.01% compared with the 0.84% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 26.17% as against Sensexs 7.27% decline.

The small-cap company has equity capital of Rs 48.48 crore. Face value per share is Re 1.

Jammu & Kashmir Bank (J&K Bank)s total income fell 1.69% to Rs 1816.67 crore in Q2 September 2016 over Q2 September 2015.

The banks gross non-performing assets (NPAs) stood at Rs 5682.96 crore as on 30 September 2016 as against Rs 4714.92 crore as on 30 June 2016 and Rs 3081.68 crore as on 30 September 2015.

The ratio of gross NPAs to gross advances stood at 11.33% as on 30 September 2016 as against 9.31% as on 30 June 2016 and 6.46% as on 30 September 2015.

The ratio of net NPAs to net advances stood at 6.81% as on 30 September 2016 as against 6.19% as on 30 June 2016 and 2.78% as on 30 September 2015.

The banks provisions and contingencies (excluding tax provisions) surged 683.76% to Rs 992.08 crore in Q2 September 2016 over Q2 September 2015.

J&K Bank is the only bank in the country with majority ownership vested with a state government. The J&K state government holds 53.17% stake in the bank as at 30 September 2016.

Powered by Capital Market - Live News

Dilip Buildcon gets stronger after winning new order
Dec 16,2016

The announcement was made after market hours yesterday, 15 December 2016.

Meanwhile, the BSE Sensex was down 13.42 points, or 0.05%, to 26,496.92.

On the BSE, 26,080 shares were traded in the counter so far, compared with average daily volumes of 41,998 shares in the past one quarter. The stock had hit a high of Rs 233.90 and a low of Rs 228 so far during the day.

Dilip Buildcon announced that the company has been declared as successful bidder by the Ministry of Road Transport and Highways, Government of India for the project of rehabilitation and upgradation of Machilipatnam to Avinigadda section of NH-214A to two lane with paved shoulder in Andhra Pradesh.

The project was awarded under The National Highways Development Project (NHDP)-IV through engineering, procurement and construction (EPC) basis at a project cost of Rs 260.10 crore having length 34.40 kilometers and completion period of 24 months.

Shares of Dilip Buildcon were listed on the stock market on 11 August 2016.

Dilip Buildcons net profit fell 82.7% to Rs 6.97 crore on 3.5% increase in net sales to Rs 915.66 crore in Q2 September 2016 over Q2 September 2015.

Dilip Buildcon is one of the leading road-focused engineering, procurement and construction (EPC) contractors in India.

Powered by Capital Market - Live News

Tata Comm gains after subsidiary receives approval from ICASA for its acquisition
Dec 16,2016

The announcement was made after market hours yesterday, 15 December 2016.

Meanwhile, the S&P BSE Senses was up 3.87 points or 0.01% at 26,522.94.

On the BSE, 65,013 shares were traded on the counter as against the average daily volumes of 1.25 lakh shares in the past one quarter. The stock had hit a high of Rs 669.65 and a low of Rs 635 so far during the day.

Tata Communications said that this is another step towards closing of the transaction.

Tata Communications had announced on 28 June 2016, that Liquid Telecom, a pan-African telecoms group, majority owned by Econet Wireless Global, had entered into an agreement to acquire South African communications network operator Neotel, which is a subsidiary of Tata Communications.

Thereafter, on 8 November 2016, Tata Communications had informed that the board of directors of the company at a meeting held on 8 November 2016 recommended to the shareholders of Neotel, the sale of the entire shareholding in Neotel, subject to approval of the Independent Communications Authority of South Africa (ICASA).

Tata Communications consolidated net profit tanked 64.4% to Rs 39.96 crore on 0.2% decline in net sales to Rs 4509.09 crore in Q2 September 2016 over Q2 September 2015.

Tata Communications owns and operates the worlds largest and most advanced subsea fibre cable network.

Powered by Capital Market - Live News